Cancer guidelines need to fit the care people can actually access. This editorial calls for local evidence, affordable options and equity to shape recommendations from the start.
@ishukataria3@SullivanProf
https://t.co/klamGzV8tR
Quite simply, a brilliantly written review on Chinese Pharma - From 2015 to 2024, over 393 cancer medicines were approved worldwide, 72 were China's branded new medicines. eg; zanubrut, tisleliz, avaprit, toripali, fruquin. @SullivanProf@kjmeetswrld
https://t.co/oJdtodGJUU
What are the immediate and long-term implications of war for cancer care? Our editorial in @bmjoncology explores this question through lessons from Ukraine. With @gmbowsher, @SullivanProf, and Kateryna Denysenko: https://t.co/22sdOdhyAZ
Our new article about @WHO essential cancer medicines published today in JAMA Oncology with @SullivanProf
We ask: how to implement these medicines?
https://t.co/hufDE1ynVI
Final report from cancer conference organised by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, held in Vatican City in 2025 https://t.co/goXBwP1V4m
Report from the Pontifical Academy of Sciences & European Academy of Cancer Sciences meeting held in Vatican City. A complex picture of innovation, global inequity & increasing divergence between science & systems implementation. https://t.co/goXBwP2sTU @WHO@EU_Commission
The stark realities of healthcare for displaced people. As conflict's worsen so too does the problem. Yet we are seeing societal attitudes worsen and protection increasingly eroded. https://t.co/n7pVLhYl5C
Important work by @DavidiTawfiles & our team in @TheLancet: "#Health#equity and displaced people: challenges, progress, and the path forward."
🌍🌎🌏This #InternationalMigrantsDay, heath of those most vulnerable should be a global priority
🔗 https://t.co/uwOSSTof4r
We're excited to be hosting this @LGCW2025 event with @KingsCollegeLon hosted by Richard @SullivanProf today! 🌟🙌👇
Check out the details below and join us online - or look out for the recording which will be shared on the event page and via our channels soon 📽️🗓️